Abingworth LLP Transaction History

Date Transaction Value Shares Traded Form
Jan 31 2022
BUY
Open market or private purchase
$4,050,000 $27.0 p/Share
150,000
Jan 28 2022
BUY
Exercise of in-the-money or at-the-money derivatives securities
$3,794,617 $13.2 p/Share
287,471

Also insider at

SIEN
Sientra, Inc. Healthcare
TARA
Protara Therapeutics, Inc. Healthcare
PSNL
Personalis, Inc. Healthcare
SLNO
SOLENO THERAPEUTICS INC Healthcare
PCVX
Vaxcyte, Inc. Healthcare
VERA
Vera Therapeutics, Inc. Healthcare
EFTR
eFFECTOR Therapeutics, Inc. Healthcare
JSPR
Jasper Therapeutics, Inc. Healthcare
AL

Abingworth LLP

> 10% Shareholder
London, X0

Track Institutional and Insider Activities on SRRA

Follow Sierra Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRRA shares.

Notify only if
Any

Insider Trading

Get notified when an Sierra Oncology, Inc. insider buys or sells SRRA shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Sierra Oncology, Inc.

Track Activities on SRRA